GHRP-2
Second-Generation Growth Hormone Releasing Peptide
GHRP-2 is the most potent of the classical GHRPs in terms of GH release per dose. It produces a strong GH pulse via ghrelin receptor agonism, but unlike ipamorelin, it also raises cortisol and prolactin — a tradeoff that defines its research niche: maximum GH release when selectivity is not the priority.
At a Glance
GHRP-2 was developed as a second-generation improvement over GHRP-6 — retaining strong GH release while reducing the pronounced appetite stimulation that characterized its predecessor. The result is a potent secretagogue that still produces meaningful cortisol and prolactin elevation, but is more manageable for body composition research than GHRP-6.
Its strong GH release makes it the preferred GHRP when maximum GH elevation is the research objective and hormonal selectivity is secondary — such as in potency comparison studies or models studying downstream IGF-1 responses to high GH stimulation.
In research contexts requiring the cleanest possible GH signal without hormonal noise, ipamorelin is generally preferred. GHRP-2 is preferred when GH potency is the primary variable.
This compound operates through several converging biological pathways, which helps explain the breadth of effects observed across different tissue and metabolic models.
GHSR-1a Agonism
Strongly activates the ghrelin receptor to trigger GH release from the pituitary — the most potent GHSR-1a agonist in the classical GHRP class.
High GH Release
Produces the largest acute GH pulse of the GHRP class — greater than ipamorelin or GHRP-6 at equivalent doses in comparison studies.
Cortisol & Prolactin
Activates pathways beyond GHSR-1a, raising cortisol and prolactin — a relevant confound in studies where these hormones affect the outcome.
IGF-1 Upregulation
Strong GH release drives robust IGF-1 elevation, making it useful for studies requiring maximum downstream anabolic signaling.
- GH potency studies — highest raw GH release of classical GHRP class
- IGF-1 elevation research — maximum GH stimulus for downstream response studies
- Body composition — lean mass and fat mass in combination with CJC-1295
- GH deficiency models — potent stimulation for poorly responsive pituitary models
- Comparison studies with ipamorelin and GHRP-6 — defining the selectivity/potency tradeoff
- Wound healing and tissue repair — GH/IGF-1 mediated regeneration
- Anti-aging — high-dose GH stimulation models
GHRP-2, ipamorelin, and GHRP-6 form a selectivity spectrum — choose based on whether clean GH isolation or maximum output is the research priority.
| Aspect | GHRP-2 | Ipamorelin | GHRP-6 |
|---|---|---|---|
| GH Release Potency | Highest | Moderate | Moderate |
| Cortisol Release | Moderate elevation | Minimal | Moderate elevation |
| Prolactin Release | Moderate elevation | Minimal | Moderate elevation |
| Appetite Stimulation | Mild | None | Strong |
| Best Use | Potency / IGF-1 studies | Selectivity studies | Appetite + GH combo |
Highest GH release of the classical GHRP class — preferred for maximum secretagogue output studies
More selective than GHRP-6 — less appetite stimulation while retaining potency
Well-characterized pharmacology — extensively studied half-life, receptor kinetics, and GH release patterns
Cortisol and prolactin elevation — a meaningful confound in studies where these hormones affect the outcome variable
This overview is strictly educational and based on publicly available scientific literature as of 2026. It does not constitute medical advice. All Helixera Labs products are for laboratory research use only. Not for human or veterinary use. · Helixera Labs LLC © 2026